How can adopting data-driven manufacturing and advanced analytics optimize cell health data, build predictive models, and ensure quality control, to ultimately making these therapies more accessible and cost-effective?
Of Interest To:
Developers, Regulators, Policy-Makers, Biomanufacturers, CDMOs, Investors, Researchers, Data Scientists, Quality Professionals, Manufacturers, Lab Professionals, Cold Chain Professionals, Industry, Quality Personnel, Enablers, Start-Ups, Business Development Professionals, Manufacturing & Processing Centers, Lab Directors, PIs, Operations Upper-Management